Jefferies Initiates Spectrum Pharmaceuticals With Hold

Analysts at Jefferies initiated coverage on Spectrum Pharmaceuticals SPPI with a Hold rating. The target price for Spectrum Pharmaceuticals is set to $8. Spectrum Pharmaceuticals shares have dropped 20.96% over the past 52 weeks, while the S&P 500 index has surged 15.18% in the same period. Spectrum Pharmaceuticals' shares rose 0.40% to $7.42 in after-hours trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: InitiationAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!